Walleye Trading’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Walleye Trading’s Portfolio NAMSW Stock Details NAMSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,084	Closed	-$41K	–	5134
2023 Q4	$41K	Hold	13,084	–	–	﹤0.01%	4379
2023 Q3	$24.9K	Sell	13,084 -5,400	-29%	-$10.5K	﹤0.01%	4347
2023 Q2	$38.6K	Buy	18,484 +3,528	+24%	+$7.59K	﹤0.01%	4005
2023 Q1	$27.5K	Sell	14,956 -1,400	-9%	-$2.22K	﹤0.01%	4199
2022 Q4	$14.2K	Buy	+16,356	New	+$13.5K	﹤0.01%	4417

Other funds holding NAMSW

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Walleye Trading's NAMSW Position: Q1 2024 in Review

Walleye Trading sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2024, closing a stake of 13,084 shares — an estimated $41K sold.

Walleye Trading first reported a position in NAMSW in Q4 2022 and held it in 5 quarters. The position peaked at $41K in Q4 2023. 11 funds tracked by Wall St. Rank hold NAMSW as of Q1 2024.

Walleye Trading reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2024 after selling out during the quarter.
Walleye Trading sold 13,084 NewAmsterdam Pharma Warrant shares in Q1 2024, an estimated $41K.
Walleye Trading first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 5 quarters.
Walleye Trading's NewAmsterdam Pharma Warrant position peaked at $41K in Q4 2023.
11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.